We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNI icon
76
Nelnet
NNI
$4.81B
$1.02M 0.31%
+11,544
New +$999K
LBRDK icon
77
Liberty Broadband Class C
LBRDK
$4.44B
$995K 0.3%
+12,342
New +$1.04M
GTES icon
78
Gates Industrial Corporation Ltd.
GTES
$6.72B
$984K 0.3%
+73,358
New +$868K
MPT
79
Medical Properties Trust
MPT
$2.86B
$983K 0.3%
200,230
+151,942
+315% +$744K
EXE
80
Expand Energy Corp
EXE
$21.7B
$971K 0.29%
+12,617
New +$1.04M
SFM icon
81
Sprouts Farmers Market
SFM
$7.23B
$959K 0.29%
+19,928
New +$872K
TMO icon
82
Thermo Fisher Scientific
TMO
$208B
$956K 0.29%
1,802
+1,110
+160% +$537K
BOOT icon
83
Boot Barn
BOOT
$4.71B
$941K 0.28%
+12,265
New +$922K
WSO icon
84
Watsco Inc
WSO
$15B
$935K 0.28%
+2,183
New +$846K
PG icon
85
Procter & Gamble
PG
$346B
$933K 0.28%
6,364
+4,772
+300% +$707K
RVNC
86
DELISTED
Revance Therapeutics, Inc.
RVNC
$926K 0.28%
+105,295
New +$863K
EVBG
87
DELISTED
Everbridge, Inc. Common Stock
EVBG
$919K 0.28%
+37,812
New +$815K
SYY icon
88
Sysco
SYY
$40.2B
$916K 0.28%
+12,522
New +$864K
META icon
89
Meta Platforms (Facebook)
META
$1.51T
$913K 0.28%
+2,578
New +$840K
CCJ icon
90
Cameco
CCJ
$38.9B
$912K 0.28%
+21,164
New +$886K
G icon
91
Genpact
G
$5.45B
$892K 0.27%
+25,687
New +$886K
OMCL icon
92
Omnicell
OMCL
$1.89B
$891K 0.27%
+23,672
New +$871K
NOW icon
93
ServiceNow
NOW
$109B
$876K 0.26%
+6,200
New +$781K
NYT icon
94
New York Times
NYT
$11.7B
$867K 0.26%
+17,705
New +$781K
ICLR icon
95
Icon
ICLR
$13B
$866K 0.26%
+3,061
New +$792K
SILK
96
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$866K 0.26%
70,590
+58,447
+481% +$548K
CIEN icon
97
Ciena
CIEN
$53.4B
$865K 0.26%
19,211
+14,357
+296% +$633K
VRNT
98
DELISTED
Verint Systems
VRNT
$859K 0.26%
+31,775
New +$737K
PM icon
99
Philip Morris
PM
$305B
$857K 0.26%
+9,114
New +$840K
AGRO icon
100
Adecoagro
AGRO
$1.48B
$857K 0.26%
+77,172
New +$849K
2 3
4
5 6

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.